Impact of Covid-19 on Non-Alcoholic Steatohepatitis (NASH) Market 2020 Outlook Ready for Prosperous Growth by Revenue Till 2027 : Genfit, Gilead Sciences, Inventiva
Non-Alcoholic Steatohepatitis (NASH) Market Size – USD 0.41 billion in 2018, Growth - CAGR of 52.9%, Trends – Growing adoption of NASH therapeutics.
View full press release